Cargando…

Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization

BACKGROUND: Chromogenic in situ hybridization (CISH) is fast becoming a well established technique for easy and sensitive determination of HER2 gene status in breast cancer. However, for the chromogenic method to achieve status as a safe and reliable technique, the method needs to be validated again...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mollerup, Jens, Henriksen, Ulla, Müller, Sven, Schønau, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Technical Advance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305592/ https://www.ncbi.nlm.nih.gov/pubmed/22333181 http://dx.doi.org/10.1186/1472-6890-12-3

Ejemplares similares

Optimizing Ventana chromogenic dual in-situ hybridization for mucinous epithelial ovarian cancer
por: Li, Xinyun, et al.
Publicado: (2013)

Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens
por: García-Caballero, Tomás, et al.
Publicado: (2010)

Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization for Low and High Throughput HER2 Genetic Testing
por: Poulsen, Tim S., et al.
Publicado: (2013)

Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients
por: Cao, Pengfei, et al.
Publicado: (2017)

Combined Fluorescent-Chromogenic In Situ Hybridization for Identification and Laser Microdissection of Interphase Chromosomes
por: Paz, Nerea, et al.
Publicado: (2013)

DNA breakage detection-fluorescence in situ hybridization in buccal cells
por: Cortés-Gutiérrez, E.I., et al.
Publicado: (2012)

Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
por: Rosa, F.E., et al.
Publicado: (2013)

Determination of HER-2 status on FNAC material from breast carcinomas using in situ hybridization with dual chromogen visualization with silver enhancement (dual SISH)
por: Beraki, Elsa, et al.
Publicado: (2010)

Correlation of AR, EGFR, and HER2 Expression Levels in Prostate Cancer: Immunohistochemical Analysis and Chromogenic In Situ Hybridization
por: Baek, Kwang Hyun, et al.
Publicado: (2012)

Reference genes for quantitative Arabidopsis single molecule RNA fluorescence in situ hybridization
por: Duncan, Susan, et al.
Publicado: (2022)

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
por: Reis-Filho, Jorge S, et al.
Publicado: (2005)

Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study
por: Ordás, Javier, et al.
Publicado: (2007)

Monosomy 3 by chromogenic in situ hybridization (CISH) in Iranian patients with uveal melanoma
por: Naseripour, Masood, et al.
Publicado: (2015)

Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer
por: Park, Kyeongmee, et al.
Publicado: (2011)

Mapping pachytene chromosomes of coffee using a modified protocol for fluorescence in situ hybridization
por: Iacia, Ana Amélia Sanchez, et al.
Publicado: (2013)

Comparison of Chromogenic In Situ Hybridisation with Fluorescence In Situ Hybridisation and Immunohistochemistry for the Assessment of Her-2/neu Oncogene in Archival Material of Breast Carcinoma
por: Pothos, Alexios, et al.
Publicado: (2008)

Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma
por: Rosa, Fabíola E, et al.
Publicado: (2009)

Evaluating HER2 Gene Amplification Using Chromogenic In Situ Hybridization (CISH) Method In Comparison To Immunohistochemistry Method in Breast Carcinoma
por: Atabati, Hadi, et al.
Publicado: (2018)

ChromaWizard: An open source image analysis software for multicolor fluorescence in situ hybridization analysis
por: Auer, Norbert, et al.
Publicado: (2018)

Single molecule chromogenic in situ hybridization assay for RNA visualization in fixed cells and tissues
por: Jiang, Meng, et al.
Publicado: (2019)

Chromogenic in situ hybridization technique for detecting porcine circovirus 3 in lung and lymphoid tissues
por: Tan, Chew Yee, et al.
Publicado: (2023)

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)
por: Nitta, Hiroaki, et al.
Publicado: (2008)

Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure
por: Bischel, Lauren L, et al.
Publicado: (2015)

Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status
por: Madrid, Manuelito A, et al.
Publicado: (2004)

Chromogenic in situ Hybridization Compared with Real time Quantitative Polymerase Chain Reaction to Evaluate HER2/neu Status in Breast Cancer
por: Ayatollahi, Hossein, et al.
Publicado: (2017)

Chromogenic in Situ Hybridization Technique versus Immunohistochemistry in Assessment of HER2/neu Status in 448 Iraqi Patients with Invasive Breast Carcinoma
por: Ali, Ali Hussein Mohammed, et al.
Publicado: (2019)

In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy
por: Weiswald, Louis-Bastien, et al.
Publicado: (2010)

Detection of Epstein Barr Virus by Chromogenic In Situ Hybridization in cases of extra-hepatic biliary atresia
por: Mahjoub, Fatemeh, et al.
Publicado: (2008)

Detection of Tritrichomonas foetus and Pentatrichomonas hominis in intestinal tissue specimens of cats by chromogenic in situ hybridization
por: Mostegl, Meike M., et al.
Publicado: (2012)

Molecular probes for the identification of avian Haemoproteus and Leucocytozoon parasites in tissue sections by chromogenic in situ hybridization
por: Himmel, Tanja, et al.
Publicado: (2019)

A CRISPR/Cas9‐mediated in situ complementation method for Phytophthora sojae mutants
por: Qiu, Min, et al.
Publicado: (2021)

HER-2/neu Oncogene Amplification by Chromogenic in situ Hybridization in 130 Breast Cancers Using Tissue Microarray and Clinical Follow-up Studies
por: Chang, Eundeok, et al.
Publicado: (2004)

A dual fluorescent multiprobe assay for prion protein genotyping in sheep
por: Van Poucke, Mario, et al.
Publicado: (2005)

Multi-target Chromogenic Whole-mount In Situ Hybridization for Comparing Gene Expression Domains in Drosophila Embryos
por: Hauptmann, Giselbert, et al.
Publicado: (2016)

Comparison of Her-2, EGFR and Cyclin D1 in Primary Breast Cancer and Paired Metastatic Lymph Nodes: An Immunohistochemical and Chromogenic In Situ Hybridization Study
por: Cho, Eun Yoon, et al.
Publicado: (2008)

Fluorescent in situ Hybridization on Mitotic Chromosomes of Mosquitoes
por: Timoshevskiy, Vladimir A., et al.
Publicado: (2012)

Sexing of Dog Sperm by Fluorescence In Situ Hybridization
por: OI, Maya, et al.
Publicado: (2012)

Fluorescence In Situ Hybridization (FISH) and Its Applications
por: Shakoori, Abdul Rauf
Publicado: (2017)

Establishing a protocol for immunocytochemical staining and chromogenic in situ hybridization of Giemsa and Diff-Quick prestained cytological smears
por: Beraki, Elsa, et al.
Publicado: (2012)

Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
por: Caldwell, Charles, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u7agak0m2t4tdfhv76626jorq4